G&E Herbal Biotechnology Co., Ltd. (4911)
TWSE
27.90
-0.10 (-0.36%)
Closed
Oct 12, 2026
Day's Range
27.7027.90
52 wk Range
27.3546.48
Financial Statements - 4911 - G&E Herbal Biotechnology Co., Ltd.
Revenue
309.13M▲ 24.1%
Net Income
139.19M▲ 36.4%Net Margin 45.0%
EBITDA
169.02M▲ 25.1%
Free Cash Flow
66.97M▼ 48.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 309.13M | 249.03M | 181.44M | 64.60M | 24.57M | 28.23M |
| Cost of Goods | 45.91M | 43.68M | 36.85M | 25.25M | 14.94M | 16.21M |
| Gross Profit | 263.22M | 205.34M | 144.58M | 39.35M | 9.62M | 12.01M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 152.30M | 119.64M | 80.68M | 5.48M | -19.56M | -15.47M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 158.39M | 124.72M | 90.50M | 7.22M | -18.22M | -13.05M |
| Income Tax | 19.19M | 22.66M | 18.10M | -154K | 1.66M | 1.24M |
| Net Income | 139.19M | 102.06M | 72.40M | 7.38M | -19.88M | -14.30M |
| EPS Basic | 2.018519 | 1.601852 | 1.226415 | 0.122642 | -0.339623 | -0.245283 |
| EPS Diluted | 2.018519 | 1.601852 | 1.226415 | 0.122642 | -0.339623 | -0.245283 |
| Basic Shares Outstanding | 68.81M | 63.72M | 58.99M | 58.99M | 58.99M | 58.99M |
| Diluted Shares Outstanding | 68.81M | 63.72M | 58.99M | 58.99M | 58.99M | 58.99M |
| Ebit | 158.42M | 124.76M | 90.50M | 7.22M | -19.56M | -15.47M |
| Ebitda | 169.02M | 135.14M | 99.83M | 16.62M | -10.22M | -6.25M |
| Net Income Continuous Operations | 158.39M | 124.72M | 90.50M | 7.22M | -18.22M | -13.05M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
